T1	interaction 1015 1021	higher
T2	pharmacokinetics 1022 1043	plasma concentrations
T3	drug 1047 1057	felodipine
T4	food 1069 1085	grapefruit juice
T5	interaction 1100 1114	greater change
T6	function 1118 1132	blood pressure
T7	food 1189 1194	water
T8	mode 148 156	drinking
T9	food 157 173	grapefruit juice
T10	mode 17 25	drinking
T11	pharmacokinetics 181 202	acute pharmacokinetic
T12	drugEffect 207 227	haemodynamic actions
T13	drugClass 235 250	dihydropyridine
T14	drugClass 251 269	calcium antagonist
T15	food 26 42	grapefruit juice
T16	drug 270 280	felodipine
T17	dosage 292 296	5 mg
T18	mode 303 309	tablet
T19	population 330 362	nine, healthy, middle-aged males
T20	food 376 381	water
T21	food 383 399	grapefruit juice
T22	interaction 410 418	increase
T23	pharmacokinetics 422 426	Cmax
T24	value 427 453	from mean 6 to 16 nmol.l-1
T25	pharmacokinetics 466 469	AUC
T26	value 470 494	from 23 to 65 nmol.h.l-1
T27	pharmacokinetics 50 66	pharmacokinetics
T28	pharmacokinetics 510 513	AUC
T29	interaction 533 541	increase
T30	pharmacokinetics 549 570	systemic availability
T31	drug 574 584	felodipine
T32	value 585 599	from 15 to 45%
T33	interaction 610 619	no change
T34	pharmacokinetics 627 636	clearance
T35	interaction 673 683	inhibition
T36	pharmacokinetics 691 700	oxidation
T37	drug 704 714	felodipine
T38	drug 731 748	dehydrofelodipine
T39	component 752 762	flavonoids
T40	food 766 782	grapefruit juice
T41	food 805 821	grapefruit juice
T42	drug 83 93	felodipine
T43	drugClass 863 879	dihydropyridines
T44	pharmacokinetics 884 893	oxidation
T45	drugClass 901 916	dihydropyridine
T46	drug 943 962	pyridine derivative
A1	valence T29 Augmentation
A2	valence T22 Augmentation
R3	enzyme_inhibition Arg1:T40 Arg2:T37	
R2	enzyme_inhibition Arg1:T39 Arg2:T37	
R4	enzyme_inhibition Arg1:T41 Arg2:T43	
R5	metabolism_decrease Arg1:T41 Arg2:T43	
R6	physiological_effect_antagonism Arg1:T4 Arg2:T3	
#1	AnnotatorNotes R3	présence de "oxydation" juste avant permet cette relation ; sinon, metabolism_decrease
R1	metabolism_decrease Arg1:T39 Arg2:T37	
R7	metabolism_decrease Arg1:T40 Arg2:T37	
#2	AnnotatorNotes R6	blood pressure. Effet/impact clinique démontré, impact significatif pour patient ; Traduction clinique de l'intéraction cinétique. Ne correspond pas à un mécanisme d'interaction
